Treatment of a severely bleeding patient without preexisting coagulopathy with activated recombinant factor VII

American Journal of Medicine

Volumn 108, Issue 5, 2000, Pages 421-423

  Vlot, André J ^a   Ton, Evelien ^a   MacKaay, Albert J C ^a   Kramer, Mark H H ^a   Gaillard, Carlo A J M ^a  

^a EEMLAND HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7; OCTREOTIDE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID;

ADULT; ARTICLE; BLEEDING; CASE REPORT; DRUG EFFICACY; DUODENUM BLEEDING; DUODENUM ULCER; HEMATEMESIS; HUMAN; MALE; MELENA; PRIORITY JOURNAL;

FACTOR VIIA; HEMATEMESIS; HUMANS; LAPAROTOMY; MALE; MELENA; MIDDLE AGED; PEPTIC ULCER HEMORRHAGE; RECOMBINANT PROTEINS; RECURRENCE; REOPERATION; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0034177740     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00398-8     Document Type: Article

References (9)

1. Laine L., Peterson W.L. Bleeding peptic ulcer. NEJM. 331:1994;717-727.
2. Hedner U., Glazer S., Pingel K., et al. Successful use of recombinant factor VIIa in a patient with severe hemophilia A during synovectomy. Lancet. ii:1988;1193.
3. Lusher J.M. Recombinant factor VIIa (Novoseven) in the treatment of internal bleeding in patients with factor VIII and IX inhibitors. Haemostasis. 26:(suppl 1):1996;124-130.
4. Kristensen J., Killander A., Hippe E., et al. Clinical experience with recombinant factor VIIa in patients with thrombocytopenia. Haemostasis. 26:(suppl 1):1996;159-164.
5. Peters M., Heijboer H. Treatment of a patient with Bernard-Soulier syndrome and recurrent nosebleeds with recombinant factor VIIa. Thromb Haemost. 80:1998;352.
6. Tengborn L., Petruson B. A patient with Glanzmann thrombasthenia and epistaxis successfully treated with recombinant factor VIIa. Thromb Haemost. 75:1996;981-982.
7. Meijer K., Sieders E., Slooff M.J.H., et al. Effective treatment of severe bleeding due to acquired thrombocytopathia by single dose administration of activated recombinant factor VII. Thromb Haemost. 80:1998;204-205.
8. Rapaport S.I., Rao L.V. The tissue factor pathway how it has become a 'prima ballerina.' . Thromb Haemost. 74:1995;7-17.
9. Ten Cate H., Bauer K.A., Levi M., et al. The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor. J Clin Invest. 92:1993;1207-1212.